Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.045 USD | -2.97% | -2.43% | +19.21% |
May. 15 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
May. 09 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.21% | 763M | |
+17.89% | 125B | |
+13.87% | 109B | |
-3.39% | 24.74B | |
+2.71% | 22.67B | |
-9.95% | 18.14B | |
-41.48% | 16.67B | |
-12.00% | 16.64B | |
+0.07% | 13.45B | |
+21.92% | 11.32B |
- Stock Market
- Equities
- WVE Stock
- News Wave Life Sciences Ltd.
- -Analyst Actions: RBC Cuts Price Target on WAVE Life Sciences to $8 From $13, Maintains Sector Perform Speculative Risk